11.12.2012 Views

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

continued from part 1 - Controller General of Patents, Designs, and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION (21) Application No.6792/DELNP/2008 A<br />

(19) INDIA<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application :07/08/2008 (43) Publication Date : 24/10/2008<br />

(54) Title <strong>of</strong> the invention : "PYRROLO [3,2-C] PYRIDINE-4-ONE 2-INDOLINONE PROTEIN KINASE INHIBITORS"<br />

(51) International classification :C07D 47/04 (71)Name <strong>of</strong> Applicant :<br />

(31) Priority Document No :200610003229.6 1)SHANGHAI HENGRUI PHARMACEUTICAL CO. LTD.<br />

(32) Priority Date :27/01/2006<br />

Address <strong>of</strong> Applicant :NO.279 WENJING ROAD,<br />

(33) Name <strong>of</strong> priority country :China<br />

MINHANG DISTRICT, SHANGHAI 200245, CHINA. China<br />

(86) International Application No :PCT/CN2007/000256 (72)Name <strong>of</strong> Inventor :<br />

Filing Date<br />

:24/01/2007<br />

1)TANG, PENG CHO<br />

(87) International Publication No :WO 2007/085188 2)SU, YIDONG<br />

(61) Patent <strong>of</strong> Addition to Application<br />

Number<br />

Filing Date<br />

:NA<br />

:NA<br />

3)ZHANG, LEI<br />

4)XIAO, LU<br />

(62) Divisional to Application Number :NA<br />

Filing Date<br />

:NA<br />

(57) Abstract :<br />

The present invention relates to pyrrolo[3,2-c]pyridine-4-one 2-indolinone compounds <strong>of</strong> Formula (I) <strong>and</strong> their pharmaceutically<br />

acceptable salts there<strong>of</strong>, wherein R1, R2, R3, R4, R5, R6, R7, R8 X , Y <strong>and</strong> &mldr,: have the meaning cited in the specification. Also<br />

disclosed are the pharmaceutical compositions containing the foregoing compounds, methods for the preparation <strong>and</strong> pharmaceutical<br />

use there<strong>of</strong>, <strong>part</strong>icularly as protein kinase inhibitors.Formula (I)<br />

No. <strong>of</strong> Pages : 217 No. <strong>of</strong> Claims : 32<br />

The Patent Office Journal 24/10/2008 26233

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!